CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST

被引:259
作者
BERTILSSON, L
CARRILLO, JA
DAHL, ML
LLERENA, A
ALM, C
BONDESSON, U
LINDSTROM, L
DELARUBIA, IR
RAMOS, S
BENITEZ, J
机构
[1] KAROLINSKA INST,HUDDINGE HOSP,DEPT MED LAB SCI & TECHNOL,DIV CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
[2] UNIV EXTREMADURA,SCH MED,DEPT PHARMACOL,E-06071 BADAJOZ,SPAIN
[3] UPPSALA UNIV,PSYCHIAT RES CTR,S-75017 UPPSALA,SWEDEN
关键词
CLOZAPINE; CAFFEINE; CYP1A2;
D O I
10.1111/j.1365-2125.1994.tb04385.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a previous study we showed that the disposition of clozapine after a single oral dose is unrelated to either debrisoquine or S-mephenytoin hydroxylation polymophism. The same 14 healthy subjects studied in that investigation were given 150 mg of caffeine. The reciprocal of plasma clozapine AUC (0,24), was correlated with an index of the N3-demethylation of caffeine (r(s) = 0.84; P = 0.0024), used as a measure of cytochrome P4501A2 (CYP1A2) activity. N1- and N7-demethylation indices of caffeine also reflect CYP1A2 activity and were also correlated with clozapine clearance (r(s) = 0.89 and 0.85; P = 0.0013 and 0.0023; respectively). No significant relationships with xanthine oxidase and N-acetyl transferase activity, also assessed by a caffeine test, were found. This study suggests that clozapine is metabolised by CYP1A2 to a major extent.
引用
收藏
页码:471 / 473
页数:3
相关论文
共 50 条
  • [41] Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls
    Petersen, Maria Skaalum
    Halling, Jonrit
    Damkier, Per
    Nielsen, Flemming
    Grandjean, Philippe
    Weihe, Pal
    Brosen, Kim
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (12) : 1041 - 1048
  • [42] Simultaneous Quantification of Antioxidants Paraxanthine and Caffeine in Human Saliva by Electrochemical Sensing for CYP1A2 Phenotyping
    Anastasiadi, Rozalia-Maria
    Berti, Federico
    Colomban, Silvia
    Tavagnacco, Claudio
    Navarini, Luciano
    Resmini, Marina
    ANTIOXIDANTS, 2021, 10 (01) : 1 - 18
  • [43] CYP1A2 polymorphism-1545C > T (rs2470890) is associated with increased side effects to clozapine
    Viikki, Merja
    Kampman, Olli
    Seppala, Niko
    Mononen, Nina
    Lehtimaki, Terho
    Leinonen, Esa
    BMC PSYCHIATRY, 2014, 14
  • [44] Diurnal variation in CYP1A2 enzyme activity in South Asians and Europeans
    Perera, Vidya
    Gross, Annette S.
    McLachlan, Andrew J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (02) : 264 - 270
  • [45] Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers
    Shirley, KL
    Hon, YY
    Penzak, SR
    Lam, YWF
    Spratlin, V
    Jann, MW
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (05) : 961 - 966
  • [46] Changes in CYP1A2 Activity in Humans after 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Administration Using Caffeine as a Probe Drug
    Yubero-Lahoz, Samanta
    Pardo, Ricardo
    Farre, Magi
    Mathuna, Brian O.
    Torrens, Marta
    Mustata, Cristina
    Perez-Mana, Clara
    Langohr, Klaus
    Carbo, Marcel-li
    de la Torre, Rafael
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (06) : 605 - 613
  • [47] Correlation of Cytochrome P450 (CYP) 1A2 Activity Using Caffeine Phenotyping and Olanzapine Disposition in Healthy Volunteers
    Kara Lee Shirley
    Yuen Y Hon
    Scott R Penzak
    YW Francis Lam
    Vicky Spratlin
    Michael W Jann
    Neuropsychopharmacology, 2003, 28 : 961 - 966
  • [48] Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis
    Ortega-Vazquez, Alberto
    Mayen-Lobo, Yerye G.
    Davila-Ortiz de Montellano, David J.
    Tristan-Lopez, Luis
    Avina-Cervantes, Carlos L.
    Rios, Camilo
    Lopez-Lopez, Marisol
    Monroy-Jaramillo, Nancy
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (05) : 685 - 694
  • [49] INDUCTION OF HEPATIC CYP1A2 BY THE ORAL-ADMINISTRATION OF CAFFEINE TO RATS - LACK OF ASSOCIATION WITH THE AH LOCUS
    AYALOGU, EO
    SNELLING, J
    LEWIS, DFV
    TALWAR, S
    CLIFFORD, MN
    IOANNIDES, C
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1272 (02): : 89 - 94
  • [50] Quantification of caffeine in human saliva by Nuclear Magnetic Resonance as an alternative method for cytochrome CYP1A2 phenotyping
    Schievano, Elisabetta
    Finotello, Claudia
    Navarini, Luciano
    Mammi, Stefano
    TALANTA, 2015, 140 : 36 - 41